An article featuring commentary from Dr. Nuala Murphy regarding the use of decentralised and hybrid trials during the COVID-19 crisis.
Read articleRelated information
Webpage
COVID-19 clinical operations
Webpage
Digital Disruption
Blog
COVID-19 vaccine trials
Blog
Diagnostics on the frontlines of COVID-19
Blog
Preparing for Disease X, a look at the potential impact of Coronavirus
Blog
Minimise the impact of COVID-19 on clinical trials with in-home clinical services
Blog
Managing trial participants with cardiovascular and metabolic disease during COVID-19
Blog
COVID-19, Influenza and cardiovascular disease - What is known?
Blog